Opioid overdose and cardiovascular disease-related mortality: a retrospective analysis using real-world data from the USA, 1999–2023 - Report - MDSpire
Advertisement
Opioid overdose and cardiovascular disease-related mortality: a retrospective analysis using real-world data from the USA, 1999–2023
Clinical Report: Cardiovascular Disease Mortality Associated with Opioid Overdose
Overview
This study reveals a significant increase in cardiovascular disease (CVD) mortality associated with opioid overdose from 1999 to 2023, highlighting disparities among demographic groups. The findings underscore the urgent need for integrated strategies addressing both opioid use and cardiovascular health.
Background
Cardiovascular disease is a leading cause of death in the U.S., and its intersection with the opioid epidemic poses a growing public health challenge. The rising rates of opioid overdose deaths have been linked to worsening CVD outcomes, necessitating a comprehensive understanding of these trends. This study aims to inform healthcare strategies that address the dual burden of CVD and opioid-related mortality.
Data Highlights
Year
AAMR (per 100,000)
Men
Women
NH Black
West Region
Non-Metro
1999
0.36
2.51
0.99
0.33
2.11
1.56
2023
4.08
2.51
0.99
6.48
2.11
1.56
Key Findings
112,430 deaths involving both opioid overdose and CVD were identified from 1999 to 2023.
The age-adjusted mortality rate (AAMR) increased from 0.36 in 1999 to 4.08 in 2023 (AAPC: 10.96; p < 0.001).
Men had higher mortality rates than women (AAMRs: 2.51 vs. 0.99).
Non-Hispanic Black individuals experienced the steepest increase in AAMR (from 0.33 to 6.48).
Middle-aged adults (45-64 years) had the highest crude mortality rate (CMR) at 2.94.
Non-metropolitan areas consistently showed higher AAMRs compared to metropolitan areas (1.56 vs. 1.47).
Clinical Implications
Healthcare providers should be aware of the increasing mortality associated with opioid overdose and CVD, particularly among vulnerable populations. Integrated care approaches that address both substance use and cardiovascular health are essential for improving patient outcomes. Enhanced screening and preventive measures in high-risk demographics may mitigate these trends.
Conclusion
The significant rise in CVD mortality linked to opioid overdose highlights an urgent public health issue. Addressing this dual epidemic requires coordinated efforts in prevention, treatment, and health system resilience.
by Mohamed Fawzi Hemida, Alyaa Ahmed Ibrahim, Maryam Saghir, Ahmed Elshahat, Mohammad Rayyan Faisal, Moaz Elsayed Abouelmagd, Zeyad Kholeif, Krish Patel, Noha Hammad, Pakeezah Tabasum, Eshal Saghir, Mohammed Hammad Jaber Amin, Ahmed Elmorsy Mohamed, Khaled Ali, Basel Abdelazeem, Mustafa Al-jarshawi
